10 Biotech and Pharma Stocks to Buy According to Billionaire Steve Cohen
In this piece, we will take a look at 10 biotech and pharma stocks to buy according to billionaire Steve Cohen.
Kadmon Holdings Inc. (KDMN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Anson Investments Amin Nathoo And Moez Kassam | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | ||
| 3. | 0 | $0 | 0% | ||
| 4. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% | |
| 5. | Point72 Asset Management Steve Cohen | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.93 | 16,000 | 152,945 | 2020-03-13 | Filing | ||
| $3.24 | 21,693 | 31,000 | 2020-03-12 | Filing | ||
| $3.24 | 9,307 | 9,307 | 2020-03-12 | Filing | ||
| $3.96 | 12,600 | 136,945 | 2020-03-11 | Filing | ||
| $3.40 | 1,470,588 | Other | 14,636,334 | 2019-11-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.04 | 1,709 | Large Shareholder | 131,147 | 2017-06-29 | Filing | |
| $4.04 | 7,498 | Large Shareholder | 575,117 | 2017-06-29 | Filing | |
| $4.04 | 50,490 | Large Shareholder | 2,733,955 | 2017-06-29 | Filing | |
| $4.04 | 62 | Large Shareholder | 4,806 | 2017-06-29 | Filing | |
| $4.04 | 3,155 | Large Shareholder | 241,997 | 2017-06-29 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
5 New Stock Picks of Billionaire Mario Gabelli
In this article, we discuss the 5 new stock picks of billionaire Mario Gabelli.
Is Kadmon Holdings, Inc. (KDMN) A Good Stock To Buy?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Kadmon Holdings, Inc. (KDMN) Fell Out Of Favor With Hedge Funds
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
Is KDMN Stock A Buy or Sell?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
10 Best Small-Cap Biotech Stocks Under $10 in 2021
We like healthcare and technology industries because of their above-average long-term growth prospects. Biotechnology is at the intersection of healthcare and technology.
5 Best Small-Cap Biotech Stocks Under $10 in 2021
Below we presented the list of 5 best small-cap biotech stocks under $10 in 2021.
Hedge Funds Keep Buying Kadmon Holdings, Inc. (KDMN)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Did Hedge Funds Make The Right Call On Kadmon Holdings, Inc. (KDMN) ?
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC.
Hedge Funds Aren't Done Buying Kadmon Holdings, Inc. (KDMN)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.